CD8A and neoplasm: Formation of tertiary lymphoid structures (TLS) at the tumor-stroma interface is associated with augmented antigen presentation, a favorable CD8+/Treg ratio, and improved patient survival, whereas an immune-excluded phenotype characterized by CD8+ T cells restricted to the tumor periphery without core infiltration is often linked to poor responses to immune checkpoint inhibitors (29, 30).